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Degenerative pathology of the first metatar-
sophalangeal (MTP) joint, known as hallux rigidus, 
was first described in 1887 by Davies-Colley-Cotterill 
apud Faraj(1) and involves progressive loss of joint 
range of motion, pain on mobilization (especially 
in dorsiflexion) and deformity. It affects about 2% 
of the population aged over 50 years(2), is prevalent 
among females, and is associated with the first long 
metatarsal, flat MTP joint, and a history of hyper-
extension injury. 
Several therapeutic options are available depending 
on the degenerative stage of the MTP joint, which may 
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Objective: To evaluate the preliminary results from 
the METIS-Newdeal® metatarsophalangeal prosthesis 
for treating hallux rigidus grade III/IV. Methods: This 
was a prospective study on eight metatarsophalangeal 
prostheses that were placed in six patients between 
November 2007 and July 2009. The patients’ mean age 
was 55 years and the mean follow-up after the surgery 
was 50 weeks. The results were evaluated using the 
AOFAS-MTP score and x-ray images as controls. 
Results: The AOFAS-MTP score increased significantly 
from 42p before the surgery to 82p after the surgery 
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level. No intercurrences were identified radiologically. 
Among the five patients who underwent operations, only 
one expressed dissatisfaction with the surgery: this was 
expressed after early infection appeared at the surgical 
site, and it was the only postoperative complication found. 
Conclusion: Total metatarsophalangeal arthroplasty using 
METIS-Newdeal® presented promising short-term results. 
However, evaluations on a larger number of cases with 
a longer follow-up are needed in order to draw more 
consistent conclusions.
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Arthroplasty
include conservative supporting measures through to 
surgical procedures, such as cheilectomy, phalangeal 
or first metatarsal osteotomy, Keller procedure or MTP 
arthrodesis. MTP arthroplasty was first proposed in the 
late 19th century by Heuter, using an acrylic prosthesis(3). 
Since then various evolutions of the procedure have 
been presented. In 1979, Swanson proposed the use 
of the interposition silicone prosthesis (Silastic®)
(4). However, these prostheses presented several 
complications, including fracture of the prosthesis 
and synovitis and bone lysis related to worn particles 
of silicone(5-7). In 1994, the use of zirconium ceramic 
components (Moje®) was tested, but these materials 
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also presented several complications, particularly due 
to fracture of the material(2,8,and 9).
Other materials and solutions were proposed in an 
attempt to find a prosthesis model that would replicate 
the anatomy and biomechanics of the normal joint, 
and at the same time, enable long-lasting use.
This work presents the preliminary results of 
eight MTP arthroplasties performed at the Centro 
Hospitalar do Porto – Hospital de Santo António 
(CHP-HSA), using the METIS-Newdeal® prosthesis, 
with anaverage follow-up period of 50 weeks .
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The prosthesis
The METIS® prosthesis consists of three compo-
nents: metatarsal (cobalt-chromium alloy), phalan-
gel (titanium), and a third-generation interposition 
component composed of polyethylene. Metatarsal and 
phalangeal components are coated with hydroxyapati-
te. The design seeks to preserve the normal anatomy 
of the MTP joint, preserving the sesamoid bones and 
their tendinous insertions, with an expected range of 
motion of about 85° (-20:0:60) (Figure 1).
grades 3 and 4). The patient group consisted of four 
male and two female patients, with an average age of 
55 years (42-63) at the time of surgery. The main co-
morbidity was diabetes mellitus affecting two patients 
who were being treated for that pathology.
All the patients were evaluated before the surgery 
using the AOFAS-MTP (American Orthopaedic Foot 
& Ankle Society) score for the metatarsophalangeal 
joint, which ranges between 0 and 100 points and eva-
luates parameters such as pain (40p), function (45p) 
and alignment (15p).
All the surgeries were performed by the same 
surgeon, using the same surgical technique. In the 
immediate postoperative period, the patients were en-
couraged to perform passive and active movements 
(as tolerated), followed by two weeks of walking with 
partial weight-bearing, using Baruk shoes with crutch 
support. The first observation in an outpatient clinic 
was made on day 15 when the stitches were removed. 
Six weeks after the surgery, a follow-up radiography 
was taken to evaluate the integration and alignment 
of the prosthesis, and the collection of information 
began, to complete the AOFAS-MTP score. The pa-
tients were also asked to report their satisfaction in 
relation to the surgery by stating whether they would 
undergo the surgery again. The average follow-up 
time was 50 weeks (13-64). 
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Preoperative results
The AOFAS-MTP score had an average of 42 
points (12-52), with partial scores of: pain (19p), 
function (15p) and alignment (8p). Before surgery, 
all the patients reported expectations of decreased 
pain and improved walking ability as decisive factors 
in their decision to undergo surgery.
Postoperative results
On reassessment in the outpatient clinic, there was 
a significant increase in the average AOFAS-MTP 
score, to 82 points (50-95) (Figure 2). Analyzing this 
score, an increase was observed in all the partial sco-
res: pain (33p), function (36p) and alignment (14p). 
The results were most evident at the function level, 
for which the point increase was 2.4 times higher, 
compared with the preoperative scores (Table 1).
The trial
A prospective trial was conducted between No-
vember 2007 and July 2009 to evaluate the clinical 
and functional results of eight total MTP arthroplas-
ties using the METIS® prosthesis in six patients at the 
CHP-HSA. Two patients were submitted (in different 
surgical times) to bilateral arthroplasty. For all the pa-
tients, the surgery was indicated due to painful hallux 
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In the radiological analysis, none of the implants 
showed signs of early suture, fracture or problems of 
misalignment of the components (Figure 3).
Regarding the patients’ level of satisfaction after 
surgery, only one patient reported being disappointed 
with the results, owing to an infectious complication 
that affected the results.
Complications
One patient had an intraoperative complication 
in which the proximal phalange of the hallux was 
fractured. However, this fracture did not prevent the 
completion of the surgery, and no modification to 
the postoperative protocol used was needed. In the 
follow-up, the results were similar to those of patients 
without any complications.
One patient had infection at the surgery site seven 
weeks after surgery. The patient was treated immedia-
tely with oral antibiotics (amoxicillin + clavulanate) 
and was apparently cured. In relation to the results, 
in the first seven weeks the patient showed an im-
provement in the AOFAS-MTP score in relation to 
their preoperative score; after the infection, the sco-
re decreased dramatically, and this patient had the 
worst results of the study group. This was also the 
only patient who reported being disappointed with 
the surgery, stating that they would never undergo 
the procedure again.
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Depending on the degree of the hallux rigidus, 
cheilectomy, Keller procedure and MTP arthrodesis 
are considered the gold standard treatment for this pa-
thology. Despite showing good results in many cases, 
these procedures are not without failures and compli-
cations. Cheilectomy has been used with good results 
for pain relief only in the initial stages, when the joint 
space and the range of mobility are preserved, or it is 
limited to pain on dorsiflexion only(10). However, it 
is not recommended for more advanced conditions. 
In patients who already have significant MTP joint 
destruction, resection of the proximal portion of the 
first phalange (Keller procedure) or MTP arthrodesis 
are the traditional options. Although the Keller pro-
cedure preserves an acceptable range of MTP mo-
tion, it does so at the expense of losing driving force 
when walking, and is not indicated for younger or 
active middle-aged patients. In the long term, the de-
velopment of central transfer metatarsalgia in about 
30% of patients(11) or swan neck deformity, can cause 
problems with the use of standard footwear. Arthro-
desis of the first MTP is considered by many as the 
treatment to be adopted for young or active patients 
because it has positive results in the long term, in 
relieving pain and preserving the transfer of driving 
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Pain 19 33   1.73x
Function 15 36  !2.4x
Alignment 8 14  !1.75x
AOFAS-MTP 42 82  !1.95x
(ACD4'5'6'Partial and total values of the AOFAS-MTP scale
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forces to the hallux, even enabling the practice of cer-
tain sports activities(12). However, studies have shown 
that this is a surgery that has a high failure rate in 
first metatarsophalangeal joint fusion (> 20%)(1) and 
although a successful arthrodesis does not usually 
require surgical revision, this joint fusion alters the 
biomechanics of the forefoot. Many patients develop 
calluses under other metatarsal heads, due to weight 
transfer, and pain is often experienced in the hallux 
interphalangeal joint(1). Many patients also report that 
although they are able to perform daily activities with 
less pain, they can no longer wear regular footwear. 
This is predominantly reported by young female pa-
tients (26%) – they are no longer able to wear high 
heels – and individuals who are frequently required 
to adopt a squatting position.
MTP arthroplasty has the advantage that it offers 
relief of symptoms, keeping the anatomy and transfer 
of force as close to normal as possible.
Historically, several models of MTP prosthesis 
have been proposed. However, all of these models had 
complications that prevented their use as an ongoing 
treatment of hallux rigidus.
The silicone prostheses were first introduced in 
1979 by Swanson et al(4). In studies to evaluate the 
results of these prostheses (Silastic®), we found wide 
variability in the conclusions, ranging from long-term 
success(13,14) to early failure. Shankar(5), in 1995, pre-
sented a trial involving 40 patients with an average 
follow-up period of 110 months, in which the com-
plication rate was 36%, mainly due to fragmentation 
of the silicone. A high incidence of granulomatous 
reactions to silicone particles is also reported in about 
72% of patients, and causes significant osteolysis(6,7).
In 1994, Townley and Taranow(15) developed a 
phalangeal hemiarthroplasty prosthesis made from 
titanium. However, the results were similar to those of 
older silicone prostheses, and they did not live up to 
the expectations(16). Raikin et al(17) presented a study 
comparing the results of 21 hemiarthroplasties and 27 
MTP arthrodeses in an average follow-up period of 
79 months. No advantages were found for performing 
hemiarthroplasty.
In 2002, the Medical Devices Agency of the UK 
issued a warning that led to the recall of the Moje® 
screw-fit prostheses, due to its high failure rate(2). In 
2003, Redfern et al(8) published a review of 119 pa-
tients whose results at the first year were alarming, 
with 14% of surgical revisions and 5% of prostheses 
with significant but asymptomatic osteolysis. This 
prosthesis suffered changes, and the press-fit system 
came to be used as the means of bone fixation/inte-
gration. Malviya et al(18) showed positive results with 
this new Moje system, in a 35-month follow-up study. 
However, other studies report cases of failure of the 
Moje® press-fit prosthesis, due to problems with the 
materials used (zirconium ceramic)(9). In 2007, Nixon 
and Taylor(2) published the results of a study involving 
21 prostheses, in which they found an unacceptable 
failure rate of around 29% requiring surgical revision 
and a complication rate of 71% within three years.
After the problems with the first prostheses, a new 
model of non-restrictive and anatomic prosthesis was 
introduced on the market. In 2001, Notni et al(19) 
evaluated the results of the ReFlexion® prosthesis 
(similar to METIS®), and found a significant reduc-
tion in pain and a high level of patient satisfaction 
after the surgery. These good results were supported 
by Fuhrmann(20) in 2005, who found an increase in 
the average AOFAS score from 51p (before surgery) 
to 74p (after surgery), in a follow-up period of 39 
months using the same prosthesis. Nevertheless, both 
authors verified the existence of periprosthetic image 
in half of the prostheses without clinical reference.
Analyzing the METIS® prosthesis, its advantages 
are the fact that the prosthesis maintains the meta-
tarsophalangeal joint function and range of motion 
within the normal anatomical standards; the excellent 
clinical and functional results obtained in this study, 
with an increase in the average AOFAS-MTP score 
from 42 to 82 (+40p); and the high level of patient 
satisfaction with the final result. Its disadvantages 
are the cost of the prosthesis (> €1000) compared 
with other simpler and cheaper procedures (Keller 
procedure, arthrodesis), and the fact that the implant 
requires a more demanding and time-consuming sur-
gical technique and a longer learning period.
We may suggest some modifications to the trial, 
given that it is still in its initial phase, with little 
follow-up time, and few cases under evaluation. 
The patients will be assessed in an outpatient 
basis at irregular times, and the results may be 
influenced by the learning curve of the surgeon 
and the surgical team.
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The total metatarsophalangeal joint arthroplasty 
using the METIS-Newdeal® prosthesis appears to be 
a valid alternative for the treatment of the pathologies 
affecting this joint. However, more data and a longer 
follow-up period are needed to obtain conclusive and 
statistically significant results. A long-term compari-
son of our results with those obtained from traditional 
approaches will also be necessary.
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